Archives sv-life-sciences

by in
Entry Author Date Location
ReShape Medical Lands $38,000,000 Series D Financing Round 08/26/15 San Diego
Avitide Gets $7.6M More to Purify Complex Biologics 08/06/15 Boston
Avitide Secures Series C Financing 08/06/15 Boston
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
KalVista Pharmaceuticals Lands $33,000,000 Series B Funding 07/23/15 Boston
Retooled Catabasis Cuts Price, Upsizes to Grab $60M in IPO 06/25/15 Boston
After Shift to Duchenne and Cholesterol Drugs, Catabasis Files For IPO 05/14/15 Boston
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More 02/28/14 San Diego
Thesan Pharmaceuticals Secures $49,000,000 Series B Financing 02/25/14 San Diego
AqueSys Lands $43,600,000 Series D Round 01/16/14 San Diego
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Sutro Biopharma Garners $26,000,000 Series D Funding 12/11/13 San Francisco
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Catabasis Scores $32M Series B Round With IPO in Sight 11/15/13 Boston
Catabasis Pharmaceuticals Receives $32,400,000 Series B Financing 11/14/13 Boston
Ophthotech Prices IPO at $22 Per Share, Reels in $167M 09/24/13 New York
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Tillman Gerngross’ Plan to Revamp Tech Transfer at Dartmouth 07/24/13 Boston
Ophthotech Nabs $175M To Fund Late-Stage Trial For Eye Drug 05/29/13 New York
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Ocular Therapeutix Secures $23,800,000 Series D Round 01/28/13 Boston
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Health Essentials Secures New Funding Round 10/25/12 San Diego
East Coast Life Sciences Roundup: Orphan Drugs, Financings, More 10/19/12 New York
Cibiem Obtains $10,000,000 Series A Financing 10/18/12 New York
Medical Device Company Cibiem Launches with $10 Million Series A 10/17/12 New York
Lux Bio Resurfaces With Defined Path for Pill for Rare Eye Disease 07/09/12 New York
Page 1 of 5 next page »